Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury
Introduction
Traumatic brain injury (TBI) is an environmental risk factor for the development of chronic neurodegenerative disorders, including Alzheimer's disease (AD). TBI correlates with accelerated cognitive decline in head-injured, aged subjects (Luukinen et al., 1999), and there is an increased risk for AD dementia in patients who, in adulthood, sustained a severe head injury Guo et al., 2000, McKenzie et al., 1994, Nemetz et al., 1999, Plassman et al., 2000, Roberts et al., 1991, Roberts et al., 1994, Roberts et al., 1993, Schofield et al., 1997. One of the detrimental consequences of TBI involves altered processing of amyloid precursor protein (APP), which potentially contributes to AD-like pathological cascades DeKosky et al., 1998, McIntosh et al., 1998. In AD, amyloid β peptide (Aβ) overproduction and deposition induce inflammatory cytokine infiltration with microglial activation and oxidative stress Altstiel and Sperber, 1991, Butterfield et al., 2002, Buxbaum et al., 1992, Forloni et al., 1992, Griffin et al., 1989, Griffin et al., 1995, the sequelae of which are also involved in trauma-related neurological dysfunction (Rothwell et al., 1997). TBI studies in both animal models Ciallella et al., 2002, Masumura et al., 2000, Murakami et al., 1998, Pierce et al., 1996, Smith et al., 1999, Uryu et al., 2002 and post-mortem human tissue Gentleman et al., 1993, Graham et al., 1995, McKenzie et al., 1994, Roberts et al., 1991, Roberts et al., 1994 demonstrated that increased APP production and/or accumulation can develop after injury. However, evidence of AD-like extracellular Aβ deposition has been described only in post-mortem human brain tissue so current knowledge of amyloidogenic APP metabolism and Aβ accumulation after human TBI derives almost exclusively from studies of victims of severe, lethal TBI (Roberts et al., 1994). Notably, AD-like neurodegenerative changes as well as intracellular accumulation of neurofibrillary tangle (NFT)-like pathologies were not found in these patients, with exception of subjects with repetitive head injury Geddes et al., 1999, Schmidt et al., 2001. In the present study, we collected freshly resected human brain tissue from subjects who underwent surgical treatment within hours of TBI and assessed the extent of AD-like extracellular and intracellular changes during this acute post-injury period. We further examined possible associations between these changes and variables such as subjects' age, primary lesion characteristics, hypothermia treatment, and functional outcome.
Section snippets
Subjects
The study examined 18 patients (age range 18–64 years), admitted to the University of Pittsburgh Medical Center (UPMC) between June 1999 and May 2001 for surgical treatment of severe closed head injuries (Glasgow Coma Scale, GCS score < 9). Patients' demographic and clinical variables are listed in Table 1. Data on the initial status (GCS; Teasdale and Jennett, 1974) and functional outcome at 3, 6, and 12 months after injury (Glasgow Outcome Scale, GOS; Jennett et al., 1981) were obtained for
AD plaque markers after TBI
In eight of the 18 subjects suffering severe TBI, temporal cortex contained AD-like plaque deposits (plaque-positive cases) of Aβ and/or related proteins (e.g., APP, apoE). There were no such plaques detectable in the remaining 10 (plaque-negative) TBI subjects, although some of these cases showed immunoreactive pyramidal neurons, axons, and glia (Table 3, Figs. 1D–F). Plaque-positive and plaque-negative groups were similar when compared by demographic variables and APOE genotype (percent of
Discussion
This analysis of surgically resected temporal cortex from survivors of severe TBI reveals that the formation of immunohistochemically detectable extracellular Aβ deposits can occur as early as 2 h after injury, demonstrating the extraordinary rapidity with which AD-like pathology can develop after acute neuronal insult. Extracellular deposits of Aβ, APP, and apoE were documented in 30% of subjects examined, corroborating and extending several previous post-mortem analyses Horsburgh et al., 2000
Acknowledgements
We thank Yetta I. Wilbur, Barbara A. Isanski, and Daniel Martinez for expert technical assistance. We are grateful to the University of Pittsburgh Alzheimer's Disease Research Center (AG05133), the Brain Trauma Research Center (NS30318), and Ava Puccio for brain tissue processing. We also thank Dr. Peter Davies for providing PHF-1 antibodies. Supported by NINDS NS30318, NIA AG05133, NIA AG11542, MH18273.
References (71)
- et al.
Cytokines in Alzheimer's disease
Prog. Neuro-Psychopharmacol. Biol. Psychiatry
(1991) - et al.
Frequency of stages of Alzheimer-related lesions in different age categories
Neurobiol. Aging
(1997) - et al.
Large amounts of neocortical beta A4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person
Neurosci. Lett
(1990) - et al.
Expression of amyloid precursor protein mRNAs in endothelial, neuronal, and glial cells: modulation by interleukin-1
Brain Res., Mol. Brain Res
(1992) - et al.
Molecular pathology of head trauma: altered β APP metabolism and the aetiology of Alzheimer's disease
An “anatomical cascade hypothesis” for Alzheimer's disease
Trends Neurosci
(1992)- et al.
Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aß monoclonals: evidence that an initially deposited species is Aβ42(43)
Neuron
(1994) - et al.
Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau
Neuron
(1994) - et al.
Brain trauma in aged transgenic mice induces regression of established Abeta deposits
Exp. Neurol
(2000) Immunocytochemistry of neurofibrillary tangles in dementia pugilistica and Alzheimer's disease: evidence for common genesis
Lancet
(1988)
βA4 amyloid protein deposition in brain after head trauma
Lancet
Brain trauma induces massive hippocampal neuron death linked to a surge in beta-amyloid levels in mice overexpressing mutant amyloid precursor protein
Am. J. Pathol
Antibodies to the C-terminus of the beta-amyloid precursor protein (APP): a site specific marker for the detection of traumatic axonal injury
Brain Res
Assessment of coma and impaired consciousness. A practical scale
Lancet
Parkinson's disease and related synucleinopathies are a new class of nervous system amyloidoses
Neurotoxicology
National Institute on Aging and Reagan Institute working group on diagnosis criteria for the neuropathological assessment of Alzheimer's disease. Consensus recommendations for the postmortem diagnosis of AD
Neurobiol. Aging
A high incidence of apolipoprotein E epsilon4 allele in middle-aged non-demented subjects with cerebral amyloid beta protein deposits
Acta Neuropathol
Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists
J. Alzheimer's Dis
Cholinergic agonists and interleukin-1 regulate processing and secretion of the Alzheimer ß/A4 amyloid protein precursor
Proc. Natl. Acad. Sci. U. S. A
Changes in expression of amyloid precursor protein and interleukin-1beta after experimental traumatic brain injury in rats
J. Neurotrauma
Increases in Bcl-2 and cleavage of caspase-1 and caspase-3 in human brain after head injury
FASEB
A phase II study of moderate hypothermia in severe brain injury
J. Neurotrauma
Post-traumatic Alzheimer's disease: preponderance of a single plaque type
Neuropathol. Appl. Neurobiol
Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease
Neurology
Quantitative histological studies on the aged human brain. I. Senile plaques and neurofibrillary tangles in “normal” patients
Acta Neuropathol
Secondary injury after head trauma: subacute and long-term mechanisms
Semin. Clin. Neuropsychiatry
Identification of normal and pathological aging in prospectively studied nondemented elderly humans
Neurobiol. Aging
Neuronal cytoskeletal changes are an early consequence of repetitive head injury
Acta Neuropathol
A beta 42 is the predominant form of amyloid beta-protein in the brains of short-term survivors of head injury
NeuroReport
Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease
Ann. Neurol
Distribution of B-amyloid protein in the brain following severe head injury
Neuropathol. Appl. Neurobiol
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer's disease
Proc. Natl. Acad. Sci. U. S. A
Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution
J. Neuropathol. Exp. Neurol
Head injury and the risk of AD in the MIRAGE study
Neurology
Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease
J. Neurosci
Cited by (362)
Improving quantitative susceptibility mapping for the identification of traumatic brain injury neurodegeneration at the individual level
2024, Zeitschrift fur Medizinische PhysikInflammaging, cellular senescence, and cognitive aging after traumatic brain injury
2023, Neurobiology of DiseaseNon-conducting functions of potassium channels in cancer and neurological disease
2023, Current Topics in MembranesTraumatic brain injury in women across lifespan
2022, Neurobiology of Disease